| BNGO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BNGO shares outstanding history going back to 9/21/2018:
Also see: BNGO Market Cap History BNGO YTD Return |
| BNGO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BNGO Historical Shares Outstanding: +137.92% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BNGO Stock Price Chart |
| About BioNano Genomics Inc |
| Bionano Genomics is a global genomics company focused on elevating the health and wellness of all people. Co. provides optical genome mapping, or OGM, for genome analysis and provide a suite of genome analysis solutions designed to enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Co. provides OGM and software solutions for applications across applied, translational and clinical research and it provides diagnostic services to physicians focusing in medical management for individuals with genetic conditions such as pediatric neurodevelopmental disorders, including autism spectrum disorders. Co. market and sells the Saphyr® system. We show 31 historical shares outstanding datapoints in our coverage of BNGO's shares outstanding history. Understanding the changing numbers of BNGO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BNGO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BNGO by allowing them to research BNGO shares outstanding history as well as any other stock in our coverage universe. |
| BNGO Current Stock Quote |
Quotes delayed 20 minutes  Free BNGO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| BNGO Share Performance |
| Shares Outstanding Peers |
| BioNano Genomics (BNGO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BNKK Shares Outstanding History BNTC Shares Outstanding History BOLD Shares Outstanding History BOLT Shares Outstanding History BPMC Shares Outstanding History BPTH Shares Outstanding History BRKR Shares Outstanding History BRTX Shares Outstanding History BSGM Shares Outstanding History BSPM Shares Outstanding History More Healthcare companies » |
BNGO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
